Allogene Therapeutics, Inc. (ALLO) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.87 | +34.1% |
| 2024 | $-1.32 | +36.8% |
| 2023 | $-2.09 | +12.2% |
| 2022 | $-2.38 | -77.6% |
| 2021 | $-1.34 | +49.0% |
| 2020 | $-2.63 | -43.7% |
| 2019 | $-1.83 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.87 | +34.1% |
| 2024 | $-1.32 | +36.8% |
| 2023 | $-2.09 | +12.2% |
| 2022 | $-2.38 | -77.6% |
| 2021 | $-1.34 | +49.0% |
| 2020 | $-2.63 | -43.7% |
| 2019 | $-1.83 | — |